Whole Genome Sequencing for the Analysis of Drug Resistant Strains of <i>Mycobacterium tuberculosis</i>: A Systematic Review for Bedaquiline and Delamanid

Tuberculosis (TB) remains the deadliest Infectious disease worldwide, partially due to the increasing dissemination of multidrug and extensively drug-resistant (MDR/XDR) strains. Drug regimens containing the new anti-TB drugs bedaquiline (BDQ) and delamanid (DLM) appear as a last resort for the trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Luisa Maria Nieto Ramirez (Author), Karina Quintero Vargas (Author), Gustavo Diaz (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1b003b942bcd4c9c9ec3f0b6fb3cd5df
042 |a dc 
100 1 0 |a Luisa Maria Nieto Ramirez  |e author 
700 1 0 |a Karina Quintero Vargas  |e author 
700 1 0 |a Gustavo Diaz  |e author 
245 0 0 |a Whole Genome Sequencing for the Analysis of Drug Resistant Strains of <i>Mycobacterium tuberculosis</i>: A Systematic Review for Bedaquiline and Delamanid 
260 |b MDPI AG,   |c 2020-03-01T00:00:00Z. 
500 |a 2079-6382 
500 |a 10.3390/antibiotics9030133 
520 |a Tuberculosis (TB) remains the deadliest Infectious disease worldwide, partially due to the increasing dissemination of multidrug and extensively drug-resistant (MDR/XDR) strains. Drug regimens containing the new anti-TB drugs bedaquiline (BDQ) and delamanid (DLM) appear as a last resort for the treatment of MDR or XDR-TB. Unfortunately, resistant cases to these drugs emerged just one year after their introduction in clinical practice. Early detection of resistant strains to BDQ and DLM is crucial to preserving the effectiveness of these drugs. Here, we present a systematic review aiming to define all available genotypic variants linked to different levels of resistance to BDQ and DLM that have been described through whole genomic sequencing (WGS) and the available drug susceptibility testing methods. During the review, we performed a thorough analysis of 18 articles. BDQ resistance was associated with genetic variants in <i>Rv0678</i> and <i>atpE,</i> while mutations in <i>pepQ</i> were linked to a low-level of resistance for BDQ. For DLM, mutations in the genes <i>ddn, fgd1, fbiA</i>, and <i>fbiC</i> were found in phenotypically resistant cases, while all the mutations in <i>fbiB</i> were reported only in DLM-susceptible strains. Additionally, WGS analysis allowed the detection of heteroresistance to both drugs. In conclusion, we present a comprehensive panel of gene mutations linked to different levels of drug resistance to BDQ and DLM. 
546 |a EN 
690 |a drug resistance 
690 |a wgs 
690 |a snp 
690 |a mutations 
690 |a bacteria 
690 |a clinical isolates 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 9, Iss 3, p 133 (2020) 
787 0 |n https://www.mdpi.com/2079-6382/9/3/133 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/1b003b942bcd4c9c9ec3f0b6fb3cd5df  |z Connect to this object online.